Coya Therapeutics vs Outlook Therapeutics
Coya Therapeutics is the larger business, with $7.9m of revenue in fiscal 2025 against $1.4m for Outlook Therapeutics (5.6 times as much). Coya Therapeutics grew faster (123.6% against -82.6%). Coya Therapeutics kept more of each dollar of sales as profit: a net margin of -267.1% against -4416.2%.
| Latest fiscal year | Coya TherapeuticsCOYA, 2025 | Outlook TherapeuticsOTLK, 2025 |
|---|---|---|
| Revenue | $7.9m | $1.4m |
| Revenue growth | 123.6% | -82.6% |
| Net income | −$21.2m | −$62.4m |
| Operating margin | -283.9% | — |
| Net margin | -267.1% | -4416.2% |
| Return on equity | -51.4% | — |
| Free cash flow | — | −$51.8m |
| Cash | $46.8m | $8.1m |
| Total debt | $0 | $29.9m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 17 |
| Market value | $73.5m | $86.1m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 10 buys, 0 sales |